春立醫療(01858.HK):控股股東、實際控制人承諾延長限售股鎖定期
格隆匯4月20日丨春立醫療(01858.HK)公佈,公司於2021年12月30日在上海證券交易所科創板上市,首次公開發行A股股票(以下簡稱"本次發行")完成後總股本為384,280,000股。截至公吿披露日,公司未發生增發、送股、公積金轉增股本等事項,股本總額未發生變化。
公司控股股東、實際控制人史春寶、嶽術俊對首次公開發行前股份鎖定期的承諾如下:"
1、自發行人股票上市之日起36個月內,本人不得轉讓或者委託他人管理首發上市前本人直接和間接持有的發行人股份,也不得提議由發行人回購該部分股份;本人離職的,仍繼續遵守本條承諾。
2、本人所持發行人股份在鎖定期滿後兩年內減持的,其減持價格不低於首發上市的發行價;發行人首發上市後六個月內如公司股票連續二十個交易日的收盤價均低於首發上市發行價,或者首發上市後六個月期末收盤價低於首發上市發行價,本人持有的發行人股份的鎖定期限自動延長至少六個月。
3、在前述承諾的限售期屆滿後,在本人任職期間每年轉讓的股份不超過所持發行人股份總數的百分之二十五,離職後半年內不轉讓所持的發行人股份。
4、本人違反本承諾直接或間接減持發行人股份的,違反本承諾部分的減持所得歸發行人所有,並在獲得收入的五個工作日內將前述收入支付給發行人指定賬户。如果因未履行上述承諾事項給發行人或者其投資者造成損失的,本人將向發行人或者其他投資者依法承擔賠償責任。
5、本人承諾遵守《上市公司股東、董監高減持股份的若干規定》、證券交易所及證監會等其他有關規定;若與上述股份鎖定相關的法律法規及規範性文件被修訂、廢止,本人將依據不時修訂的相關法律法規及規範性文件以及證券監管機構的有關要求進行股份鎖定及或在滿足相關條件的前提下進行減持。本人不會因為職務變更、離職等原因而拒絕履行上述承諾。"
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.